CDC Investigating Artificial Tears Product Linked to Drug-Resistant Infections By Brian Park, PharmD Publish Date February 1, 2023
FDA Issues Warning to Companies Selling Products Claiming to Treat Mpox By Brian Park, PharmD Publish Date February 1, 2023
FDA Issues Marketing Denial Orders for 2 Menthol E-Cigarette Products By Brian Park, PharmD Publish Date January 24, 2023
AstraZeneca Will Withdraw Leukemia Drug Lumoxiti From US Market By Brian Park, PharmD Publish Date January 11, 2023
Target Recalls More Than 200,000 Weighted Blankets After 2 Children Suffocated Publish Date December 28, 2022
Accord Recalls One Lot of Daptomycin for Injection By Brian Park, PharmD Publish Date December 27, 2022
Quinapril Tablets Recalled Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date December 21, 2022
Certain Detect COVID-19 Tests Recalled Due to Risk of False Negative Results By Brian Park, PharmD Publish Date December 13, 2022
FDA Pulls Authorization for Bebtelovimab Due to Nonsusceptible SARS-CoV-2 Variants By Brian Park, PharmD Publish Date December 1, 2022
Recall of Sodium Bicarbonate Injection Due to Vial Breakage Expanded By Diana Ernst, RPh Publish Date November 30, 2022
FDA: Prolia Use in Dialysis Patients May Cause Severe Hypocalcemia By Brian Park, PharmD Publish Date November 22, 2022
Companies Selling Supplements With Claims to Treat CVD Get Hit With Warning Letters By Brian Park, PharmD Publish Date November 17, 2022
Omnipod 5 Users – Safety Issue Prompts Urgent Communication By Brian Park, PharmD Publish Date November 16, 2022
Xylazine-Containing Products Complicate Overdose Management, Warns FDA By Diana Ernst, RPh Publish Date November 8, 2022
Certain Omicron Subvariants May Be Resistant to Bebtelovimab By Brian Park, PharmD Publish Date November 7, 2022
Presence of Glass Particles Prompts Recall of Octreotide Acetate Injection By Brian Park, PharmD Publish Date October 27, 2022
Quinapril-Hydrochlorothiazide Tablets Recalled Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date October 27, 2022
Reports of Vial Breakage Prompt Recall of Sodium Bicarbonate Injection By Brian Park, PharmD Publish Date October 14, 2022
Label Mix-Up Prompts Recall of Clopidogrel and Atenolol Tablets By Brian Park, PharmD Publish Date September 30, 2022
Presence of Particulate Prompts Recall of Acyclovir Intravenous Product By Brian Park, PharmD Publish Date September 28, 2022
FDA Warns of New Social Media Challenge With OTC Cough, Cold Medications By Brian Park, PharmD Publish Date September 19, 2022
FDA: Cases of Breast Implant-Related SCC, Various Lymphomas Reported By Brian Park, PharmD Publish Date September 9, 2022
Philips Recalls Certain CPAP, Bi-Level PAP Therapy Masks Due to Safety Concerns By Brian Park, PharmD Publish Date September 7, 2022
Propofol Injectable Emulsion Recalled Due to Visible Particulates in Vials By Brian Park, PharmD Publish Date August 24, 2022
Monkeypox Outbreak Prompts FDA Alert Regarding Fecal Microbiota Transplants By Brian Park, PharmD Publish Date August 23, 2022
Medication Error Possible if Incompatible Autoinjector Used to Administer MS Drug By Brian Park, PharmD Publish Date August 22, 2022
Warning Letter Issued to Company Marketing Illegal Nicotine Flavored Gummies By Brian Park, PharmD Publish Date August 18, 2022
FDA: Nitrosamine Impurity Detected in Diabetes Drug Sitagliptin By Brian Park, PharmD Publish Date August 10, 2022
Companies Selling Unapproved Drugs for Mole, Skin Tag Removal Get FDA Warning Letter By Brian Park, PharmD Publish Date August 10, 2022
OTC Laxative Recall Expanded; Vi-Jon Investigating 3 Reports of Adverse Events By Brian Park, PharmD Publish Date July 27, 2022
Lesion Swab Samples Should Be Used to Test for Monkeypox By Diana Ernst, RPh Publish Date July 18, 2022
Hospira Announces Propofol Recall Due to Possible Particulate in Vial By Brian Park, PharmD Publish Date July 15, 2022
FDA Cracks Down on Honey-Based Products Tainted With Undeclared Drugs By Brian Park, PharmD Publish Date July 13, 2022
Insulin Biosimilar Recalled Due to Missing Label on Prefilled Pens By Brian Park, PharmD Publish Date July 6, 2022
Morphine Sulfate Extended-Release Tablets Recalled Due to Incorrect Labeling By Brian Park, PharmD Publish Date July 5, 2022
FDA Warns of Increased Side Effects, Death Risk With Duvelisib By Diana Ernst, RPh Publish Date June 30, 2022
IBS-C Treatment Zelnorm Withdrawn From the Market Again By Brian Park, PharmD Publish Date June 30, 2022
Microbial Contamination Prompts Recall of Homeopathic Allergy Medicine By Brian Park, PharmD Publish Date June 15, 2022
Homeopathic Med Used for Snoring Recalled Due to Microbial Contamination By Brian Park, PharmD Publish Date June 13, 2022
Antacid, Constipation Products Recalled Due to Microbial Contamination By Brian Park, PharmD Publish Date June 10, 2022
FDA Withdraws Approval of Ukoniq Over Safety Concerns By Brian Park, PharmD Publish Date June 2, 2022
Dissolution Test Failure Prompts Recall of Anagrelide Capsules By Steve Duffy Publish Date May 26, 2022
FDA Issues Safety Alert for COVID-19 Test Over Concerns of False Results By Brian Park, PharmD Publish Date May 12, 2022
FDA Warns of Potential Chemical Exposure With Certain Hemodialysis Machines By Brian Park, PharmD Publish Date May 9, 2022
Warning Letters Sent to Companies Marketing Delta-8 THC Products as Treatments By Brian Park, PharmD Publish Date May 4, 2022
Microbial Contamination Prompts Recall of Suspending Agent Used in Compounding By Steve Duffy Publish Date May 3, 2022
FDA: Airway Obstruction Possible With Silicone-Based EMG Endotracheal Tubes By Diana Ernst, RPh Publish Date May 2, 2022
Investigation Into Counterfeit HIV Med Spurs Legal Action By Diana Ernst, RPh Publish Date April 27, 2022
Accupril Tablets Recalled Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date April 25, 2022
Hidden Drugs Found in Supplements Promoted for Musculoskeletal Conditions By Diana Ernst, RPh Publish Date April 21, 2022
Risk of False Results Possible With Noninvasive Prenatal Screening Tests By Diana Ernst, RPh Publish Date April 20, 2022
Warning Letters Sent to Companies Illegally Selling OTC Skin Lightening Products By Brian Park, PharmD Publish Date April 19, 2022
Ukoniq Taken Off the Market; Pending Applications for CLL, SLL Withdrawn By Brian Park, PharmD Publish Date April 15, 2022
Missing Label on Vial Prompts Recall of Long-Acting Insulin Analog By Brian Park, PharmD Publish Date April 13, 2022
Warning Letters Sent to Online Pharmacies Illegally Selling Schedule II Stimulants By Brian Park, PharmD Publish Date April 12, 2022
Idarubicin Hydrochloride Injection Recalled Due to Presence of Particulate in Vial By Brian Park, PharmD Publish Date April 1, 2022
FDA: Monitor Young Children for Thyroid Dysfunction After Exposure to Iodinated Contrast Media By Brian Park, PharmD Publish Date March 31, 2022
Nitrosamine Impurity Detected in Certain Lots of Orphenadrine Citrate ER Tablets By Brian Park, PharmD Publish Date March 24, 2022
Accuretic, Authorized Generics Recalled Due to Nitrosamine Impurity By Brian Park, PharmD Publish Date March 23, 2022
Reports of Injuries Prompt FDA Alert on Proper At-Home COVID-19 Test Use By Brian Park, PharmD Publish Date March 23, 2022
Syringe Malfunction Prompts Recall of Anaphylaxis Treatment By Brian Park, PharmD Publish Date March 22, 2022
FDA Recommendations for Current Shortage of Prefilled Saline Flush Syringes By Brian Park, PharmD Publish Date March 21, 2022
FDA: Do Not Use Renuvion/J-Plasma Device for Skin Improvement Procedures By Diana Ernst, RPh Publish Date March 16, 2022
FDA Tells Philips Respironics to Increase Awareness of Product Recall By Diana Ernst, RPh Publish Date March 11, 2022
Certain Immune Globulin Products Withdrawn Due to Higher Rate of Hypersensitivity Reactions By Brian Park, PharmD Publish Date March 9, 2022
Sodium Acetate Injection Recalled Due to Particulate Matter in Vials By Brian Park, PharmD Publish Date March 7, 2022
FDA: These Unauthorized COVID-19 Tests Should Not Be Used By Brian Park, PharmD Publish Date March 2, 2022
FDA: Safety Concerns With Compounded Ketamine Nasal Spray By Brian Park, PharmD Publish Date February 17, 2022
FDA Warns of Possible Strangulation With Enteral Feeding Set Tubing By Diana Ernst, RPh Publish Date February 9, 2022
FDA: Empowered Diagnostics COVID-19 Tests Should Not Be Used By Brian Park, PharmD Publish Date February 2, 2022
Polymyxin B for Injection Recalled Due to Hair Found in Vial By Brian Park, PharmD Publish Date January 31, 2022
Wound Care Gel Recalled Due to Bacterial Contamination By Brian Park, PharmD Publish Date January 27, 2022
Insulin Prefilled Pens Recalled Due to Missing Label By Brian Park, PharmD Publish Date January 20, 2022
